InvestInfoAI
Pale Fire Capital SE

Q3 2025 · 13F-HR

Pale Fire Capital SEholdings as filed

Filed 2025-11-13 · accession 0000921895-25-003010

$913.5M
Reported value
54
Positions
2025-09-30
Period end
View analyzed profile →PRO

The Brief · Pale Fire Capital SE · Q3 2025

AI · grounded in 13F

Pale Fire Capital SE established a new position in B2GOLD CORP BTG valued at $247.6M. The fund also initiated a new stake in GROUPON INC GRPN for $237.7M and DOLE PLC DOLE for $115.4M. These moves contributed to a total AUM of $913.5M across 54 positions.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
11777Q209BTGB2GOLD CORP$247.6M27.1%50,015,909CommonSHARED
399473206GRPNGROUPON INC$237.7M26.0%10,181,070CommonSHARED
G27907107DOLEDOLE PLC$115.4M12.6%8,588,077CommonSHARED
450913108IAGIAMGOLD CORP$50.8M5.56%3,930,998CommonSHARED
644535106NGDNNEW GOLD INC CDA$44.6M4.88%6,211,037CommonSHARED
881624209TEVATEVA PHARMACEUTICAL INDS LTD$34.1M3.74%1,689,811CommonSHARED
152006102CGAUCENTERRA GOLD INC$25.1M2.74%2,335,878CommonSHARED
00183L201ANGIANGI INC$22.3M2.44%1,368,478CommonSHARED
44955L106IAUXI-80 GOLD CORP$21.5M2.36%22,518,159CommonSHARED
603170101MLYSMINERALYS THERAPEUTICS INC$20.2M2.21%532,407CommonSHARED
48123V102ZDZIFF DAVIS INC$15.3M1.68%401,825CommonSHARED
36352H100GAUGALIANO GOLD INC$14.6M1.60%6,655,735CommonSHARED
G9108L173TENTSAKOS ENERGY NAVIGATION LTD$7.6M0.83%340,619CommonSHARED
N0731H103ATAIATAI LIFE SCIENCES NV$5.7M0.63%1,080,768CommonSHARED
53635D202LQDALIQUIDIA CORPORATION$5.5M0.60%240,721CommonSHARED
50127T109KURAKURA ONCOLOGY INC$5.4M0.59%607,790CommonSHARED
67080N101NUVBNUVATION BIO INC$5.3M0.59%1,444,647CommonSHARED
878972108TECXTECTONIC THERAPEUTIC INC$4.1M0.45%259,726CommonSHARED
Y41053102INSWINTERNATIONAL SEAWAYS INC$3.5M0.38%76,059CommonSHARED
825690100SSTKSHUTTERSTOCK INC$3.2M0.35%154,278CommonSHARED
374163103GERNGERON CORP$3.1M0.34%2,281,754CommonSHARED
75901B107RGNXREGENXBIO INC$2.5M0.27%255,601CommonSHARED
23954D109DAWNGBXDAY ONE BIOPHARMACEUTICALS I$2.1M0.23%302,467CommonSHARED
142038108CRBUCARIBOU BIOSCIENCES INC$1.8M0.20%775,055CommonSHARED
00773U207AVU0ADVERUM BIOTECHNOLOGIES INC$1.6M0.18%363,282CommonSHARED
48115J109DERMJOURNEY MED CORP$1.6M0.18%228,567CommonSHARED
08975P108CMRCCOMMERCE.COM INC$1.5M0.16%298,631CommonSHARED
23256X407HELPCYBIN INC$904,1440.10%153,505CommonSHARED
L00849106AGROADECOAGRO S A$663,5540.07%84,637CommonSHARED
78463X952SPDR INDEX SHS FDS$621,2000.07%10,000PUTSHARED
98420X202XFORX4 PHARMACEUTICALS INC$618,5100.07%180,851CommonSHARED
427746102HRTXHERON THERAPEUTICS INC$593,6990.06%471,190CommonSHARED
67066G954NVDANVIDIA CORPORATION$559,7400.06%3,000PUTSHARED
219798105QDELQUIDELORTHO CORP$536,2550.06%18,209CommonSHARED
03843E104AQSTAQUESTIVE THERAPEUTICS INC$520,6080.06%93,132CommonSHARED
514766104LFCRLIFECORE BIOMEDICAL INC$475,6030.05%64,620CommonSHARED
714157203PESIPERMA-FIX ENVIRONMENTAL SVCS$457,2270.05%45,270CommonSHARED
87650L103TARSTARSUS PHARMACEUTICALS INC$420,4670.05%7,075CommonSHARED
282559103ETNBGBP89BIO INC$395,4740.04%26,903CommonSHARED
76200L309RZLTREZOLUTE INC$394,0670.04%41,922CommonSHARED
415858109HROWHARROW INC$389,9210.04%8,093CommonSHARED
04280A100ARWRARROWHEAD PHARMACEUTICALS IN$349,1420.04%10,123CommonSHARED
N44445109IMTXIMMATICS N.V$291,9800.03%34,270CommonSHARED
52886X107LXEOLEXEO THERAPEUTICS INC$223,4360.02%33,650CommonSHARED
001228501MITTAG MTG INVT TR INC$222,4710.02%30,728CommonSHARED
58039P305MUXMCEWEN INC.$217,0850.02%12,695CommonSHARED
G1110E107BHVNBIOHAVEN LTD$155,2630.02%10,344CommonSHARED
517125100LRMRLARIMAR THERAPEUTICS INC$146,0540.02%45,218CommonSHARED
00972D105AKBAAKEBIA THERAPEUTICS INC$137,0730.02%50,210CommonSHARED
92859G608VZLAVIZSLA SILVER CORP$132,7450.01%30,728CommonSHARED
29286M105ENGENE HOLDINGS INC$117,8450.01%17,254CommonSHARED
230031106CGEMCULLINAN THERAPEUTICS INC$86,6670.01%14,615CommonSHARED
68828E809ODVOSISKO DEVELOPMENT CORP$71,6410.01%21,133CommonSHARED
64782A107NEWPNEW PAC METALS CORP$70,4000.01%25,978CommonSHARED

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.